Frederik K.
- Country
- Germany
- Department
- Klinik für Dermatologie
Research Overview
- A phase 2B, multicenter, randomized, double-blind, placebo-controlled, dose-finding, efficacy and safety study of HRO350 in subjects with mild-to-moderate psoriasis (the ‘HeROPA’ study)
- Evaluation of Long-Term Safety and Efficacy of GSK1070806 in Moderate to Severe Atopic Dermatitis: A Humanised IgG1 Kappa Monoclonal Antibody Against Interleukin 18 Study
- Phase III Randomized Double-Blind Study on Efficacy and Safety of 10% vs. 5% Permethrin Cream in Scabies Treatment
Data & Insights
Has run more than one trial at 117 of 355 partner sites.
Specializations
Dermatological Research
The investigator specializes in studying therapeutic approaches for mild-to-moderate psoriasis, focusing on innovative oral treatment options for this chronic skin condition.
- Psoriasis Management
- Oral Therapeutics
- Clinical Efficacy Assessment
Their research encompasses the evaluation of novel therapeutic compounds for dermatological conditions, with particular attention to developing effective treatment protocols for psoriasis patients.
Therapeutic Development
The investigator contributes to the advancement of systemic treatments for dermatological disorders, with expertise in dose optimization and clinical response evaluation.
- Treatment Optimization
- Dose Selection Studies
- Clinical Response Assessment
Their work focuses on establishing optimal therapeutic regimens through careful evaluation of different dosing strategies in dermatological conditions.
Clinical Assessment
The investigator demonstrates expertise in comparative clinical studies, evaluating new therapeutic compounds against established treatments for dermatological conditions.
- Efficacy Evaluation
- Safety Assessment
- Treatment Comparison
Their research involves comprehensive assessment of therapeutic interventions, focusing on both efficacy and safety parameters in dermatological treatments.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.